Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 6.507.4713.0220.21-24.07

What is the latest Working Capital/Sales ratio of EMCURE PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of EMCURE PHARMACEUTICALS is 6.50 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20246.50
Mar20237.47
Mar202213.02
Mar202120.21
Mar2020-24.07

How is Working Capital/Sales of EMCURE PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2024 6.5
-12.99
Mar2023 7.47
-42.63
Mar2022 13.02
-35.58
Mar2021 20.21
Positive
Mar2020 -24.07 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹18,700.8 Cr -8% 4.7% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,142.0 Cr -1.5% 9.1% 9.1% Stock Analytics
DIVIS LABORATORIES ₹145,762.0 Cr -4.9% -0.6% 59.1% Stock Analytics
CIPLA ₹114,322.0 Cr -1.8% 1% 0.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹111,171.0 Cr 1.6% 12.1% 21.8% Stock Analytics
DR REDDYS LABORATORIES ₹92,603.7 Cr -3% -0.9% -7.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-8%

4.7%

NA
SENSEX

-2.9%

3.1%

1.8%


You may also like the below Video Courses